ScreenerHero

PBMPsyence Biomedical Ltd. Common Shares

NAS · US · Healthcare · Biotechnology · psyencebiomed.com
4.330USDMkt Cap: 16.52M $P/E: —

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap16.52M $
Enterprise Value7.55M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.94M $
Revenue/Share—
Last Price4.330 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.21
EV/Revenue—
P/S—
P/B0.53
EPS (TTM)-12.56
EPS (Forward)—
52W Range
3.94571% of range4.490
52W High4.490 USD
52W Low3.945 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-40.94%
ROA-39.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.14M $
CapEx (TTM)500.23K $
FCF Margin—
FCF Yield-30.01%
Net Debt-7.44M $
Net Debt/EBITDA1.19
Balance Sheet
Debt/Equity—
Current Ratio14.62
Quick Ratio12.12
Book Value/Sh7.389 USD
Cash/Share1.952 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split16:100
Split DateFeb 2, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.81M
Float2.61M
Insiders2.97%
Institutions9.72%
Short Interest
Short Ratio0.4d
Short % Float1.40%
Short % Out.0.98%
Shares Short37.42K
Short (prev mo.)36.01K
Technical
SMA 503.186 (+35.9%)
SMA 20019.39 (-77.7%)
Beta1.67
S&P 52W Chg21.00%
Avg Vol (30d)100.43K
Avg Vol (10d)144.94K
Technical Indicators
RSI (14)65.7
MACD0.2465
MACD Signal0.1460
MACD Hist.+0.1005
BB Upper4.323 USD
BB Middle3.501 USD
BB Lower2.678 USD
BB Width46.99%
ATR (14)0.3832 USD
Vol Ratio (20d)0.88x